Literature DB >> 29697855

Consensus and contentious statements on the use of probiotics in clinical practice: A south east Asian gastro-neuro motility association working team report.

Kok-Ann Gwee1,2, Warren Wei-Rhen Lee3, Khoon Lin Ling4, Choon Jin Ooi4, Seng Hock Quak5,6, Yock Young Dan3,7, Kewin Tien-Ho Siah7, James Guoxian Huang8,6, Andrew Seng Boon Chua9, Ida Normiha Hilmi10, Raja Affendi Raja Ali11, Christina Ong12, Marcellus Simadibrata13, Murdani Abdullah13, Jose D Sollano14, Somchai Leelakusolvong15, Sutep Gonlachanvit16, Yeong Yeh Lee17, Jane D Ricaforte-Campos18, Yee Kian Yin19, Kuck-Meng Chong20, Chong Yuen Wong21.   

Abstract

The concept of consuming microorganisms in the treatment of a medical condition and in health maintenance has gained much attraction, giving rise to an abundance of medical claims and of health supplements. This study identified relevant clinical questions on the therapeutic use of probiotics and reviewed the literature in irritable bowel syndrome, inflammatory bowel disease, impaired intestinal immunity, liver disease, intestinal infections, and common childhood digestive disorders. Statements were developed to address these clinical questions. A panel of experienced clinicians was tasked to critically evaluate and debate the available data. Both consensus and contentious statements are presented to provide to clinicians a perspective on the potential of probiotics and importantly their limitations.
© 2018 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Asia; childhood; gastrointestinal; liver; obesity; probiotics

Mesh:

Year:  2018        PMID: 29697855     DOI: 10.1111/jgh.14268

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

Review 1.  Food & mood: a review of supplementary prebiotic and probiotic interventions in the treatment of anxiety and depression in adults.

Authors:  Sanjay Noonan; Meena Zaveri; Elaine Macaninch; Kathy Martyn
Journal:  BMJ Nutr Prev Health       Date:  2020-07-06

Review 2.  Low fermentable oligosaccharides, disaccharides, monosaccharides, and polypols diet and irritable bowel syndrome in Asia.

Authors:  Yihe Zhang; Zheng Feei Ma; Hongxia Zhang; Binyu Pan; Yeshan Li; Hazreen A Majid; Yeong Yeh Lee
Journal:  JGH Open       Date:  2018-12-28

Review 3.  Second Asian Consensus on Irritable Bowel Syndrome.

Authors:  Kok Ann Gwee; Sutep Gonlachanvit; Uday C Ghoshal; Andrew S B Chua; Hiroto Miwa; Justin Wu; Young-Tae Bak; Oh Young Lee; Ching-Liang Lu; Hyojin Park; Minhu Chen; Ari F Syam; Philip Abraham; Jose Sollano; Chi-Sen Chang; Hidekazu Suzuki; Xiucai Fang; Shin Fukudo; Myung-Gyu Choi; Xiaohua Hou; Michio Hongo
Journal:  J Neurogastroenterol Motil       Date:  2019-07-01       Impact factor: 4.924

Review 4.  Use of probiotics in clinical practice with special reference to diarrheal diseases: A position statement of the Malaysian Society of Gastroenterology and Hepatology.

Authors:  Yeong-Yeh Lee; Alex H-R Leow; Pei-Fan Chai; Raja Affendi Raja Ali; Way-Seah Lee; Khean-Lee Goh
Journal:  JGH Open       Date:  2020-12-12

Review 5.  Probiotics in irritable bowel syndrome - is the quest for the right strain over? Rapid review of existing guidelines and recommendations.

Authors:  Wojciech Marlicz; Karolina Skonieczna-Żydecka; Patrycja Krynicka; Igor Łoniewski; Grażyna Rydzewska
Journal:  Prz Gastroenterol       Date:  2021-12-19

Review 6.  "Gut-brain axis": Review of the role of the probiotics in anxiety and depressive disorders.

Authors:  Eleonora Gambaro; Carla Gramaglia; Giulia Baldon; Emilio Chirico; Maria Martelli; Alessia Renolfi; Patrizia Zeppegno
Journal:  Brain Behav       Date:  2020-09-10       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.